OmniAb SPAC Presentation Deck
OMNIAB KEY PERFORMANCE INDICATORS
HIGHLY SCALABLE BUSINESS MODEL
●
Strong consistent growth in
key performance indicators
●
Active Partners(1): >30%
CAGR since 2014
Active Programs(²): >25%
CAGR since 2016
Highly scalable, with a large
number of programs
performed entirely by partners
60
50
40
30
20
10
0
Number of Active
Partners
2014
2015
2016
2017
2018
2019
2020
2021
300
250
200
150
100
50
Number of Active
Programs
17
**
2014
(1) Represents the unique number of partners with whom we have active license agreements or who have an active program.
(2) Represents programs for which an antigen is introduced into our animals and remains so as long as the program is actively being developed or commercialized.
Active Programs not tracked prior to acquisition of Open Monoclonal Technology, Inc. in January 2016.
*
2015
2016
2017
2018
2019
2020
2021
Number of Active Clinical
and Commercial Programs
25
20
15
10
5
0
2014
2015
2016
2017
2018
2019
2020
2021
29
OmniAbView entire presentation